Matthew J. O’Connor, MD
Department of Pediatrics, University of Virginia Health System, Charlottesville, Virginia
Frank T. Saulsbury, MD
Department of Pediatrics, University of Virginia Health System, Charlottesville, Virginia, firstname.lastname@example.org
|Full Text (PDF)|
|Alert me when this article is cited|
|Alert me if a correction is posted|
This report describes a 7-week-old infant with incomplete and atypical Kawasaki disease, an acute vasculitis that predominantly affects infants and children. The patient was refractory to 2 doses of intravenous immunoglobulin and to high-dose intravenous methylprednisolone. He became afebrile only after 2 doses of infliximab. His prolonged, recalcitrant course was complicated by the development of peripheral gangrene and giant coronary artery aneurysms. Infants with incomplete and atypical Kawasaki disease are prone to intravenous immunoglobulin treatment failure and are at risk for the development of coronary artery aneurysms. In such patients, we suggest that consideration be given to early aggressive therapy with corticosteroids or infliximab added to intravenous immunoglobulin.
Key Words: atypical Kawasaki disease • peripheral gangrene • infliximab
Clinical Pediatrics, Vol. 46, No. 4, 345-348 (2007)
CLINIC FOR CHILDREN
JL Taman Bendungan Asahan 5 Jakarta Indonesia 102010
phone : 62(021) 70081995 – 5703646
Clinical and Editor in Chief :
DR WIDODO JUDARWANTO
email : email@example.com
Information on this web site is provided for informational purposes only and is not a substitute for professional medical advice. You should not use the information on this web site for diagnosing or treating a medical or health condition. You should carefully read all product packaging. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider.
Copyright © 2009, Clinic For Children Information Education Network. All rights reserved.